June 30, 2021

Press release

FluoGuide enters agreement with Swedish university hospital for the second phase of the ongoing FG001 clinical trial

Copenhagen, Denmark, 30 June 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that the Company has entered... [Read more]

June 21, 2021

Press release

Minutes from Extraordinary General Meeting in FluoGuide A/S

Copenhagen, Denmark, 21 June 2021 – FluoGuide A/S, CVR no. 39 29 64 38 (“FluoGuide” or the “Company”) held an extraordinary... [Read more]

June 17, 2021

Press release

New article reveals promising results of using FluoGuide’s FG002 technology in guiding surgical removal of cancer

Copenhagen, Denmark, 17 June 2021 FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that promising preclinical data with the... [Read more]

June 4, 2021

Press release

New Board member proposed and invitation for Extraordinary General Meeting

Copenhagen, Denmark, 4 June 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) proposes the election of Mats Thorén as new board... [Read more]

June 1, 2021

Press release

FluoGuide A/S – Flagging message

Copenhagen, Denmark, 1 June 2021, FluoGuide A/S (“FluoGuide” or “the Company”) hereby announce that Arbejdernes Landsbank has informed the Company that... [Read more]

May 28, 2021

Press release

FluoGuide issue warrants to employees, management, and Board of Directors

Copenhagen, Denmark, 28 May 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that based on the approved... [Read more]

May 26, 2021

Press release

FluoGuide A/S publishes interim report for the period January – March 2021

Copenhagen, Denmark, 26 May 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January... [Read more]

May 18, 2021

Press release

FluoGuide has received green light to proceed to the next dose level with FG001 in the ongoing clinical phase I/II trial in patients undergoing surgical treatment of high grade glioma

Copenhagen, Denmark, 18 May 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that the dose escalation committee... [Read more]

May 12, 2021

Press release

FluoGuide has received approval to commence with FG001 in evening dosing in the ongoing clinical phase I/II trial in patients with high grade glioma

Copenhagen, Denmark, 12 May 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that the Danish Medicines Agency... [Read more]